Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study

Autor: Php de Jong, Ilja Tchetverikov, D. Van Zeben, Pahm van der Lubbe, Jolanda J. Luime, Aeam Weel, H Xiong, Jmw Hazes, T.M. Kuijper

Publikováno v: Scandinavian Journal of Rheumatology, 47(3), 178-184. Informa Healthcare

Objectives: To investigate whether, apart from effects of patient- and disease-related factors, psychosocial factors have additional effects on disease activity; and which factors are most influential during the first year of treatment in early rheum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f6ded9c7b3b1f8143562bc0c7276fb
https://pure.eur.nl/en/publications/12816cd7-71b7-449e-a6df-226d464caa31

A simplified fluid-sensitive MRI protocol for the hands to detect inflammation without contrast administration: a large study of symptom-free subjects from the general population as a reference for normality.

Autor: Boeren AMP; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, The Netherlands. a.boeren@erasmusmc.nl.; Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands. a.boeren@erasmusmc.nl., Ton DA; Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands., van Mulligen E; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands., Klerk BB; Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Clinical Epidemiology, Leiden University Medical Centre, Rotterdam, The Netherlands., de Jong PHP; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, The Netherlands., Oei EHG; Department of Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., Reijnierse M; Department of Radiology, Leiden University Medical Centre, Rotterdam, The Netherlands., van der Helm-van Mil AHM; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands.

Publikováno v: Skeletal radiology [Skeletal Radiol] 2024 Dec 09. Date of Electronic Publication: 2024 Dec 09.

Induction of Cure in Early Arthritis (I CEA): study protocol for an investigator-initiated randomized single-blind clinical trial with open-label extension to compare three treatment strategies in patients with newly diagnosed undifferentiated arthritis.

Autor: Bergstra SA; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. s.a.bergstra@lumc.nl., van Ouwerkerk L; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., Nevins IS; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., van der Pol JA; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., Helmich GS; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., Hest I; Patient Partner Panel, Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., van Veen A; Patient Partner Panel, Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., Bos R; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands and Department of Rheumatology, Nij Smellinghe Hospital, Drachten, the Netherlands., Goekoop-Ruiterman YPM; Department of Rheumatology, HagaHospital, the Hague, the Netherlands., Vonkeman HE; Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, the Netherlands and Department of Psychology, Health and Technology, University of Twente, Enschede, the Netherlands., Bijsterbosch J; Department of Rheumatology, Amphia Hospital, Breda, the Netherlands., de Jong PHP; Department of Rheumatology, Erasmus Medical Center, Rotterdam, the Netherlands., Güler-Yüksel M; Department of Rheumatology and Immunology, Maasstad Hospital, Rotterdam, the Netherlands., Böhringer S; Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands and Department of Pharmacology and Toxicology, Leiden University Medical Center, Leiden, the Netherlands., Huizinga TWJ; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., van Gaalen FA; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: Trials [Trials] 2024 Nov 13; Vol. 25 (1), pp. 758. Date of Electronic Publication: 2024 Nov 13.

Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis.

Autor: Looijen AEM; Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands., Snoeck Henkemans SVJ; Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands s.snoeckhenkemans@erasmusmc.nl., van der Helm-van Mil AHM; Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands.; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Welsing PMJ; Department of Rheumatology & Clinical Immunology and Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands., Koc GH; Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands., Luime JJ; Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands., Kok MR; Department of Rheumatology and Immunology, Maasstad Hospital, Rotterdam, The Netherlands., Tchetverikov I; Department of Rheumatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Korswagen LA; Department of Rheumatology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Baudoin P; Department of Rheumatology, Reumazorg Zuid West Nederland, Roosendaal, The Netherlands., Vis M; Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands., de Jong PHP; Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands.

Publikováno v: RMD open [RMD Open] 2024 Oct 18; Vol. 10 (4). Date of Electronic Publication: 2024 Oct 18.

Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial.

Autor: van Mulligen E; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands e.van_mulligen@lumc.nl.; Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands., Bour SS; Health Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, The Netherlands., Goossens LMA; Health Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, The Netherlands., de Jong PHP; Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands., Rutten-van Mölken M; Health Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, The Netherlands.; Erasmus Universiteit Rotterdam Institute for Medical Technology Assessment, Rotterdam, Zuid-Holland, The Netherlands., van der Helm-van Mil A; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.